Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...

Researchers used mitochondrial gene editing to model genetic disorders in mice, revealing profound impacts on brain function, ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

ETH researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient ...

India Block speaks to paediatrician and TV writer Dr Neal Baer about the controversial technology and how it could reshape ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...

Gene editing in the womb could be more effective than the same treatment after birth, as it is easier to deliver the ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make ...

The groundbreaking gene-editing tool that launched a patent war, earned its developers a Nobel Prize and stands poised to ...

Achieving the aggregation of different mutation types at multiple genomic loci and generating transgene-free plants in the T0 ...